Profile data is unavailable for this security.
About the company
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
- Revenue in USD (TTM)659.94k
- Net income in USD-18.97m
- Incorporated2021
- Employees19.00
- LocationMainz Biomed NVSirius Gutenberg ParkRobert-Koch-Strasse 50MAINZ 55129GermanyDEU
- Phone+49 6 131265140
- Websitehttps://www.mainzbiomed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ethema Health Corp | 15.42m | -1.44m | 2.32m | 70.00 | -- | -- | -- | 0.1503 | -0.0002 | -0.0002 | 0.002 | -0.0011 | 0.7242 | -- | 10.95 | 220,280.00 | -6.76 | 1.79 | -14.20 | -- | -- | -- | -9.34 | 3.51 | -- | 0.003 | 2.68 | -- | 12.58 | 75.64 | -282.77 | -- | -8.75 | -- |
| Aesthetic Medical Intl Hldg Grp Ltd(ADR) | 107.54m | -1.16m | 2.92m | 1.31k | -- | -- | 0.3972 | 0.0272 | -0.0213 | -0.0213 | 2.18 | -- | 1.47 | 28.52 | 74.39 | 82,155.05 | -2.45 | -30.31 | -10.38 | -77.31 | 44.14 | 50.05 | -1.67 | -28.93 | 0.2054 | 4.30 | 0.9902 | -- | 10.71 | -2.76 | 46.72 | -- | -16.53 | -- |
| Advanced Biomed Inc | 0.00 | -3.38m | 5.56m | 31.00 | -- | 1.72 | -- | -- | -0.1598 | -0.1598 | 0.00 | 0.1388 | 0.00 | -- | -- | 0.00 | -63.08 | -- | -154.97 | -- | -- | -- | -- | -- | -- | -9.33 | 0.00 | -- | -- | -- | -17.13 | -- | -- | -- |
| Mangoceuticals Inc | 466.92k | -20.12m | 5.85m | -- | -- | 0.3354 | -- | 12.52 | -3.03 | -3.03 | 0.065 | 1.13 | 0.0298 | -- | -- | -- | -126.57 | -- | -136.09 | -- | 60.62 | -- | -4,245.42 | -- | -- | -- | 0.0063 | -- | -15.81 | -- | 5.50 | -- | -- | -- |
| Mainz Biomed NV | 659.94k | -18.97m | 6.12m | 19.00 | -- | 1.10 | -- | 9.27 | -10.37 | -10.37 | 0.2919 | 0.6164 | 0.0723 | 0.4191 | 4.34 | 34,733.68 | -207.82 | -162.37 | -1,682.32 | -250.30 | 67.50 | 46.23 | -2,874.67 | -2,554.69 | 0.4314 | -26.81 | 0.4366 | -- | -0.1664 | 26.01 | 17.66 | -- | -- | -- |
| CompuMed Inc | 1.78m | -151.00k | 6.24m | 8.00 | -- | 49.08 | -- | 3.51 | -0.1337 | -0.1337 | 1.58 | 0.0997 | 2.38 | 36.71 | 4.83 | -- | -19.92 | -46.77 | -48.38 | -76.78 | 50.42 | 57.04 | -8.38 | -25.84 | 0.9493 | -2.93 | 0.7744 | -- | -1.73 | -5.71 | 64.41 | -- | -18.75 | -- |
| Univec Inc | -100.00bn | -100.00bn | 6.31m | 3.00 | -- | -- | -- | -- | -- | -- | -- | -0.0113 | -- | -- | -- | -- | -- | -50.96 | -- | -- | -- | 17.47 | -- | -198.31 | 0.0051 | -- | -- | -- | -74.07 | -64.83 | 36.83 | -- | -- | -- |
| Xcelerate Inc | 3.96m | -296.19k | 6.78m | 1.00 | -- | 4.85 | -- | 1.71 | -0.0014 | -0.0014 | 0.0189 | 0.0032 | 1.51 | 6.13 | 3.90 | -- | -11.33 | 4.24 | -49.19 | -- | 71.71 | 74.10 | -7.48 | 1.93 | 0.4797 | -0.8218 | 0.7237 | -- | 6.63 | 10.43 | 17.00 | -- | 174.06 | -- |
| Biocorrx Inc | 948.36k | -5.16m | 7.11m | 5.00 | -- | -- | -- | 7.49 | -0.3254 | -0.3254 | 0.0602 | -0.668 | 0.232 | -- | 1.49 | -- | -104.32 | -370.28 | -- | -- | 62.17 | 67.86 | -449.74 | -4,584.39 | 0.0869 | -5.40 | -- | -- | -91.40 | -49.79 | -35.55 | -- | -- | -- |
| Interpace Biosciences Inc | 41.82m | 4.64m | 8.08m | 111.00 | 65.58 | -- | 1.54 | 0.1931 | 0.0278 | -0.0035 | 1.53 | -0.0673 | 3.21 | 12.75 | 6.31 | 376,747.80 | 39.18 | -21.04 | 750.62 | -42.31 | 64.57 | 55.74 | 12.21 | -16.71 | 1.35 | 24.13 | 1.44 | -- | 17.21 | 14.14 | 186.31 | -- | 46.23 | -- |
Data as of Feb 18 2026. Currency figures normalised to Mainz Biomed NV's reporting currency: US Dollar USD
8.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 30 Sep 2025 | 394.52k | 4.35% |
| Cerity Partners LLCas of 31 Dec 2025 | 163.25k | 1.80% |
| UBS Securities LLCas of 31 Dec 2025 | 54.18k | 0.60% |
| Dauntless Investment Group LLCas of 30 Sep 2025 | 51.00k | 0.56% |
| Steward Partners Investment Advisory LLCas of 31 Dec 2025 | 30.00k | 0.33% |
| Jane Street Capital LLCas of 31 Dec 2025 | 18.44k | 0.20% |
| Journey Advisory Group LLCas of 31 Dec 2025 | 15.00k | 0.17% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2025 | 12.30k | 0.14% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2025 | 2.11k | 0.02% |
| Provenance Wealth Advisors LLCas of 31 Dec 2025 | 1.17k | 0.01% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
